Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/221115
Full metadata record
DC FieldValueLanguage
dc.contributor.authorManils Pacheco, Joan-
dc.contributor.authorWebb, Louise V.-
dc.contributor.authorHowes, Ashleigh-
dc.contributor.authorJanzen, Julia-
dc.contributor.authorBoeing, Stefan-
dc.contributor.authorBowcock, Anne M.-
dc.contributor.authorLey, Steven C.-
dc.date.accessioned2025-05-19T14:49:08Z-
dc.date.available2025-05-19T14:49:08Z-
dc.date.issued2020-06-29-
dc.identifier.issn2050-084X-
dc.identifier.urihttps://hdl.handle.net/2445/221115-
dc.description.abstractTo investigate how the CARD14E138A psoriasis-associated mutation induces skin inflammation, a knock-in mouse strain was generated that allows tamoxifen-induced expression of the homologous Card14E138A mutation from the endogenous mouse Card14 locus. Heterozygous expression of CARD14E138A rapidly induced skin acanthosis, immune cell infiltration and expression of psoriasis-associated pro-inflammatory genes. Homozygous expression of CARD14E138A induced more extensive skin inflammation and a severe systemic disease involving infiltration of myeloid cells in multiple organs, temperature reduction, weight loss and organ failure. This severe phenotype resembled acute exacerbations of generalised pustular psoriasis (GPP), a rare form of psoriasis that can be caused by CARD14 mutations in patients. CARD14E138A-induced skin inflammation and systemic disease were independent of adaptive immune cells, ameliorated by blocking TNF and induced by CARD14E138A signalling only in keratinocytes. These results suggest that anti-inflammatory therapies specifically targeting keratinocytes, rather than systemic biologicals, might be effective for GPP treatment early in disease progression.-
dc.format.extent32 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publishereLife Sciences-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.7554/eLife.56720-
dc.relation.ispartofeLife, 2020, vol. 9-
dc.relation.urihttps://doi.org/10.7554/eLife.56720-
dc.rightscc-by (c) Manils, Joan et al., 2020-
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)-
dc.subject.classificationPsoriasi-
dc.subject.classificationPèptids-
dc.subject.classificationDermatitis-
dc.subject.classificationAnimals-
dc.subject.otherPsoriasis-
dc.subject.otherPeptides-
dc.subject.otherDermatitis-
dc.subject.otherAnimals-
dc.titleCARD14E138A signalling in keratinocytes induces TNF-dependent skin and systemic inflammation-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec723848-
dc.date.updated2025-05-19T14:49:09Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid32597759-
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)

Files in This Item:
File Description SizeFormat 
250922.pdf8.39 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons